Financials
Income statement
| Fiscal date | Mar 2025 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|
| Total reported revenue | — | — | 1.7B | 1.6B |
| Cost of revenue | — | — | 1.5B | 1.4B |
| Gross profit | — | — | 224.5M | 199.7M |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | 198.4M | 197.7M |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | -17.0M | 73.7M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | 22.8M | 19.2M |
| Other income expense | — | — | — | — |
| Pretax income | — | — | 92.1M | -15.5M |
| Tax provision | — | — | 102.5M | 63.2M |
| Net income | — | — | -10.4M | -78.7M |
| Basic EPS | 0.0 | -0.1 | — | — |
| Diluted EPS | 0.0 | -0.1 | — | — |
| Basic average shares | 185.2M | 187.9M | — | — |
| Diluted average shares | 185.2M | 187.9M | — | — |
| EBITDA | — | — | 114.9M | 3.7M |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | 325K | -939K |
| Preferred stock dividends | — | — | 0 | 0 |